Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 4:39 pm Sale | 13G | Pandion Therapeutics Inc. PAND | ORBIMED ADVISORS LLC | 0 0.000% | -1,040,825 (Position Closed) | View |
| 2021-05-17 4:35 pm Sale | 13G | Pandion Therapeutics Inc. PAND | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,770,023 (Position Closed) | View |
| 2021-04-08 5:24 pm Sale | 13D | Pandion Therapeutics Inc. PAND | GSK plc GSK | 0 0.000% | -2,262,301 (Position Closed) | View |
| 2021-04-02 09:54 am Sale | 13D | Pandion Therapeutics Inc. PAND | AI Pan LLC | 0 0.000% | -2,827,883 (Position Closed) | View |
| 2021-03-04 4:48 pm Purchase | 13D | Pandion Therapeutics Inc. PAND | AI Pan LLC | 2,827,883 9.600% | 2,827,883 (New Position) | View |
| 2021-03-04 06:06 am Purchase | 13D | Pandion Therapeutics Inc. PAND | Merck & Co. Inc. MRK | 11,776,706 39.990% | 11,776,706 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | Pandion Therapeutics Inc. PAND | RA CAPITAL MANAGEMENT L.P. | 1,770,023 6.000% | 1,770,023 (New Position) | View |
| 2021-02-16 07:02 am Purchase | 13G | Pandion Therapeutics Inc. PAND | ROCHE FINANCE LTD | 3,086,084 10.500% | 3,086,084 (New Position) | View |
| 2021-02-16 06:20 am Purchase | 13G | Pandion Therapeutics Inc. PAND | Access Industries Holdings LLC | 2,827,883 9.600% | 227,110 (+8.73%) | View |
| 2021-02-12 5:16 pm Purchase | 13G | Pandion Therapeutics Inc. PAND | Polaris Partners VIII L.P. | 3,201,422 12.700% | 3,201,422 (New Position) | View |
| 2020-07-31 5:39 pm Purchase | 13D | Pandion Therapeutics Inc. PAND | GSK plc GSK | 2,262,301 7.900% | 2,262,301 (New Position) | View |
| 2020-07-31 4:26 pm Purchase | 13G | Pandion Therapeutics Inc. PAND | Versant Venture Capital VI L.P. | 3,176,507 11.100% | 3,176,507 (New Position) | View |
| 2020-07-29 9:05 pm Purchase | 13D | Pandion Therapeutics Inc. PAND | Boxer Capital LLC | 2,107,513 7.400% | 2,107,513 (New Position) | View |
| 2020-07-27 5:57 pm Purchase | 13G | Pandion Therapeutics Inc. PAND | ORBIMED ADVISORS LLC | 1,040,825 3.600% | 1,040,825 (New Position) | View |
| 2020-07-24 5:19 pm Purchase | 13G | Pandion Therapeutics Inc. PAND | Access Industries Holdings LLC | 2,600,773 9.100% | 2,600,773 (New Position) | View |